Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host intestinal epithelial cells (IECs) and gut-associated lymphoid tissue (GALT) represent the integrated structural and immunological components of the gastrointestinal barrier. IECs form a single-layer mucosal surface that regulates nutrient absorption and provides a physical defense against luminal pathogens through tight junctions and mucus secretion (Okumura & Takeda, 2017, Nature Reviews Immunology). GALT, comprising Peyer's patches, isolated lymphoid follicles, and mesenteric lymph nodes, functions as the body's largest immune compartment, responsible for inducing oral tolerance and secreting secretory IgA (Mowat & Agace, 2014, Nature Reviews Immunology). This system is a primary site of pathology in inflammatory bowel diseases (IBD) and serves as a critical reservoir for HIV-1 replication and CD4+ T-cell depletion (Brenchley & Douek, 2008, Immunity). Pharmacological targeting of this environment often involves biologics like Vedolizumab, which inhibits the alpha4beta7 integrin to prevent lymphocyte trafficking specifically to the GALT (Feagan et al., 2013, NEJM).
Therapeutic strategies involve the inhibition of lymphocyte trafficking to the gut, neutralization of pro-inflammatory cytokines (e.g., TNF-alpha, IL-12/23), and the maintenance of mucosal barrier integrity.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal epithelial cells and gut-associated lymphoid tissue (IEC/GALT).